CCA
MRK icon

Column Capital Advisors’s Merck MRK Stock Holding History

Column Capital Advisors’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$896K Buy
8,699
+3,880
+81% +$418K 0.13% 67
2023
Q2 		$556K Sell
4,819
-134
-3% -$15.2K 0.08% 80
2023
Q1 		$527K Buy
4,953
+1,156
+30% +$125K 0.08% 74
2022
Q4 		$421K Buy
3,797
+319
+9% +$32.6K 0.07% 76
2022
Q3 		$300K Buy
3,478
+7
+0.2% +$625 0.06% 85
2022
Q2 		$316K Buy
3,471
+9
+0.3% +$798 0.06% 77
2022
Q1 		$284K Buy
3,462
+373
+12% +$29.4K 0.05% 104
2021
Q4 		$237K Buy
3,089
+9
+0.3% +$717 0.05% 117
2021
Q3 		$231K Sell
3,080
-34
-1% -$2.59K 0.05% 112
2021
Q2 		$242K Sell
3,114
-156
-5% -$11.6K 0.05% 109
2021
Q1 		$241K Sell
3,270
-335
-9% -$24.7K 0.05% 103
2020
Q4 		$281K Sell
3,605
-572
-14% -$43.7K 0.07% 85
2020
Q3 		$331K Sell
4,177
-152
-4% -$11.9K 0.1% 62
2020
Q2 		$319K Buy
4,329
+373
+9% +$28.1K 0.11% 66
2020
Q1 		$290K Sell
3,956
-1
-0% -$79 0.12% 56
2019
Q4 		$343K Buy
+3,957
New +$325K 0.17% 56

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Column Capital Advisors's MRK Position: Q3 2023 in Review

Column Capital Advisors increased its Merck (MRK) stake by 81% in Q3 2023, buying an estimated $418K and bringing the position to 8,699 shares worth $896K. The position accounts for 0.13% of the portfolio, ranked #67.

Column Capital Advisors first reported a position in MRK in Q4 2019 and has held it in 16 quarters since. 3,215 funds tracked by Wall St. Rank hold MRK as of Q3 2023.

  • Column Capital Advisors held 8,699 shares of Merck worth $896K as of Q3 2023.
  • Column Capital Advisors bought 3,880 Merck shares in Q3 2023, an estimated $418K.
  • Merck made up 0.13% of Column Capital Advisors's portfolio in Q3 2023, its #67 holding.
  • Column Capital Advisors first reported a position in Merck in Q4 2019 and has held it in 16 quarters since.
  • 3,215 funds tracked by Wall St. Rank held Merck as of Q3 2023.

Based on Column Capital Advisors's 13F filing for Q3 2023, filed 3 Nov 2023.